The scientific program of 14th International Congress on Infectious Diseases has been reviewed by the American Medical Association and approved for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. One credit may be claimed for each hour of participation in approved sessions.

AMA PRA Category 1 Credit™ Claim Forms and information for US participants are available in the congress bags and at the CME counter in the registration area on Lobby Level. Completed AMA PRA Category 1 Credit™ Claim Forms must be returned to the AMA CME counter by Friday, March 12, 2010 at 18:00hrs or submitted via fax to (312) 464-5830 by May 11, 2010.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing
medical education (CME) with the European Union of Medical Spcialities (UEMS). International
physicians interested in converting AMA PRA Category 1 Credits™ to EACCME credit should contact the UEMS.

Opening hours / AMA Desk: Tuesday, March 9 to Thursday, March 11, 2010: 12:00–14:30hrs and Friday, March 12, 2010: 12:15–13:15hrs and 15:15–18:00hrs

• Be versed in the latest global efforts on malaria eradication;
• Understand the history of the discovery of HIV and comprehend how the prevention of transmission of HIV will likely unfold by looking at trends and other clues from the early 21st century;
• Understand the effect of international health and global migration on emerging infections, tropical diseases, and vaccine-preventable diseases in various mobile populations including travelers;
• Appreciate the impact on adults of Pneumococcal infections in children;
• Be aware of the microbial ecology of infectious diseases.

• Plan a rational approach for the treatment and prevention of neonatal sepsis;
• Articulate the latest updates on prevention and care of bacterial Meningitis;
• Understand the burden of Plasmodium vivax malaria in Latin America and approaches to treating the disease;
• Recognize the threat of antibiotic 'Panresistance' posed by Carbapenemase-producing bacteria and understand ways to prevent and manage this problem;
• Know the particulars of the current challenges in HIV care;
• Understand international perspectives on infection control;
• Understand the promise and limitations of short course antibiotic treatment of childhood Pneumonia ;
• Comprehend the latest information on current topics related to fungal infections;
• Understand the disease mechanism and control of MRSA infections;
• Appreciate current issues in the emergence and handling of multi drug resistant gram-negative infections
• Recognize the utility of biomarkers in the diagnosis and management of infectious diseases
• Understand the application of antimicrobial stewardship in the prevention of antibiotic resistance;
• Understand the latest information about new tools available for the management of tuberculosis around the world;
• Understand the promise of specific approaches to the elimination of AIDS.